Condition: Type 1 Diabetes Mellitus · T1DM · T1D · Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
This is a multi-center, prospective, non-interventional study that focuses on the long- term effects following participation in selected ITN new-onset Type1 Diabetes Mellitus studies with immunomodulatory agents (T1DM, T1D). This observational study will: * follow participants to determine how long they continue to produce insulin, and * will also assess how changes in the immune system over time relate to the ability to produce insulin. This information could help design better therapies for type 1 diabetes in the future.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| UCSF School of Medicine | San Francisco, California, United States | Recruiting |
| Stanford University | Stanford, California, United States | Recruiting |
| University of Colorado School of Medicine: Barbara Davis Center for Diabetes | Aurora, Colorado, United States | Recruiting |
| Yale University | New Haven, Connecticut, United States | Completed |
| Emory University | Atlanta, Georgia, United States | Withdrawn |
| Indiana University Riley Hospital for Children | Indianapolis, Indiana, United States | Recruiting |
| University of Iowa Health Care Division of Pediatric Endocrinology | Iowa City, Iowa, United States | Recruiting |
| Joslin Diabetes Center | Boston, Massachusetts, United States | Recruiting |
| University of Minnesota | Minneapolis, Minnesota, United States | Recruiting |
| Children's Mercy Hospital | Kansas City, Missouri, United States | Completed |
| Sanford Research | Sioux Falls, South Dakota, United States | Completed |
| Benaroya Research Institute | Seattle, Washington, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02734277